|
12:00–12:20
|
Distinct Clinical Features of NMO: Importance of a Timely & Accurate
Friedemann Paul (Berlin/DE) Redezeit: 20 min |
|
||
|
12:20–12:40
|
Targeting and Maximizing B-cell Depletion – should a B-cell Depleter be Used After a B-cell Deplete Failure?
Martin Weber (Göttingen/DE) Redezeit: 20 min |
|
||
|
12:40–13:00
|
New Therapeutic Options in NMOSD
Ingo Kleiter (Berg/DE) Redezeit: 20 min |
|
||
|
13:00–13:20
|
Defining Treatment Failure, what to do Next?
Orhan Aktas (Düsseldorf/DE) Redezeit: 20 min |
|
||
|
13:20–13:30
|
Q&A
Hans-Peter Hartung (Düsseldorf/DE) |
|
||